Literature DB >> 30008342

Surgical Versus Nonsurgical Management of Degenerative Joint Disease.

Shravan Kumar Renapurkar1.   

Abstract

As knowledge of the complexity of myofascial pain and its interaction with temporomandibular joint disorders has increased, the use of surgical procedures to treat degenerative joint disease has decreased. The focus has moved from a "surgery-first" approach toward a more cautious one that involves nonsurgical treatment as the primary modality, then minimally invasive treatments, followed by open surgical modalities, when indicated. This article examines the current literature regarding the effectiveness of nonsurgical and surgical treatments for the management of degenerative joint disease.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Degenerative joint disease; Osteoarthritis; Osteoarthrosis; TMJ arthralgia

Mesh:

Year:  2018        PMID: 30008342     DOI: 10.1016/j.coms.2018.04.005

Source DB:  PubMed          Journal:  Oral Maxillofac Surg Clin North Am        ISSN: 1042-3699            Impact factor:   2.802


  3 in total

Review 1.  Invasive surgical procedures for the management of internal derangement of the temporomandibular joint: a systematic review and meta-analysis regarding the effects on pain and jaw mobility.

Authors:  Roque Miguel Rodhen; Thiago Azario de Holanda; Fabíola Jardim Barbon; Wellington Luiz de Oliveira da Rosa; Noéli Boscato
Journal:  Clin Oral Investig       Date:  2022-03-15       Impact factor: 3.573

2.  Treatment of condylar osteophyte in temporomandibular joint osteoarthritis with muscle balance occlusal splint and long-term follow-up: A case report.

Authors:  Kai-Wen Lan; Jia-Min Chen; Liu-Lin Jiang; Yi-Fan Feng; Ying Yan
Journal:  World J Clin Cases       Date:  2022-05-06       Impact factor: 1.534

3.  Evaluation of the Effectiveness of Dry Needling in the Treatment of Myogenous Temporomandibular Joint Disorders.

Authors:  Juan Dib-Zakkour; Javier Flores-Fraile; Javier Montero-Martin; Sara Dib-Zakkour; Ibrahim Dib-Zaitun
Journal:  Medicina (Kaunas)       Date:  2022-02-09       Impact factor: 2.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.